XML Cancer News

Basis for new treatment options for a fatal leukemia in children revealed

published about 14 hours ago
(MC Services AG) Acute lymphoblastic leukemia is the most common type of cancer in children. It can occur in various forms, differing not only by specific changes in the genetic material of the leukemia cells but also by their response to therapies. Now, an international team of scientists from Berlin, Düsseldorf, Hannover, Heidelberg, Kiel, and Zurich succeeded in decoding the molecular characteristics of an as yet incurable subtype of leukemia, paving the way for new therapeutic approaches.

Studies reveal details of error correction in cell division

published about 14 hours ago
(University of Massachusetts at Amherst) Cell biologists led by Thomas Maresca at the University of Massachusetts Amherst, with collaborators elsewhere, report an advance in understanding the workings of an error correction mechanism that helps cells detect and correct mistakes in cell division early enough to prevent chromosome mis-segregation and aneuploidy, that is, having too many or too few chromosomes.

NYU's Bluestone Center receives $369,250 from NIDCR to study oral cancer pain

published about 14 hours ago
(New York University) The proposed studies are designed to test whether nonviral gene delivery into the oral cancer could be used to treat cancer pain effectively and safely.

Overcoming why a new treatment is resisted by lung cancer

published about 14 hours ago
(University of Manchester) A promising agent for the treatment of cancer has so far had little effect on the most common lung tumours, but new research from The University of Manchester has suggested how this resistance might be overcome.

Omega-3 fatty acids may help improve treatment and quality of life in cancer patients

published 1 day ago
(American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)) Adding omega-3 fatty acids to anti-tumor medications may improve treatment response and quality of life for cancer patients according to a new study by researchers at the University Hospitals of Leicester in the United Kingdom.